The “January – March 2020 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)”, which is sometimes called the FDA Watch List, includes an item about all vascular endothelial growth factor inhibitors medicines, i.e., the VEGF inhibitors class of drugs. As regards those VEGF … [Read more...]